ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22 | -99.8% | 2,113 | -4.5% | 0.00% | +100.0% |
| Q3 2022 | $12,000 | +100.0% | 2,213 | -41.8% | 0.00% | – |
| Q2 2022 | $6,000 | -45.5% | 3,800 | -52.5% | 0.00% | – |
| Q1 2022 | $11,000 | -47.6% | 8,000 | -77.7% | 0.00% | -100.0% |
| Q4 2021 | $21,000 | -63.8% | 35,900 | +232.4% | 0.00% | -66.7% |
| Q3 2021 | $58,000 | +41.5% | 10,800 | +36.6% | 0.00% | +200.0% |
| Q2 2017 | $41,000 | -6.8% | 7,904 | -13.2% | 0.00% | -50.0% |
| Q1 2017 | $44,000 | +144.4% | 9,104 | +193.3% | 0.00% | +100.0% |
| Q4 2016 | $18,000 | 0.0% | 3,104 | -80.1% | 0.00% | 0.0% |
| Q3 2016 | $18,000 | -82.2% | 15,604 | -42.0% | 0.00% | -83.3% |
| Q2 2016 | $101,000 | -25.2% | 26,903 | +10.9% | 0.01% | -33.3% |
| Q1 2016 | $135,000 | +3.8% | 24,259 | +12.5% | 0.01% | +28.6% |
| Q4 2015 | $130,000 | – | 21,559 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |